GREEN ANDREW M
SVP, Regulatory and Quality
SaleAlert
- Shares
- 11,480
- Price
- $24.97
- Value
- $286,656
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•67 filings
AORT
ARTIVION, INC.
Net sales of $2.6M over the last 3 months
3 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$2,557,677
0 buyers · 3 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$12,065,552
7 distinct insiders
Highlighted alerts
25
9 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get AORT insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
AORT overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
34
Voluntary view
P/S trades after deterministic checks
72
Administrative noise
Stored, never alerted
22
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 616
- Price
- $28.55
- Footnotes
- 1
These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
GREEN ANDREW M
SVP, Regulatory and Quality
SaleAlert
- Shares
- 1,493
- Price
- $26.02
- Value
- $38,842
GREEN ANDREW M
SVP, Regulatory and Quality
SaleAlert
- Shares
- 6,510
- Price
- $27.27
- Value
- $177,495
Mackin James P
President & CEO
SaleAlert
- Shares
- 70,000
- Price
- $28.96
- Value
- $2,026,850
Holloway Jean F
SVP, General Counsel
SaleAlert
- Shares
- 977
- Price
- $28.49
- Value
- $27,835
GREEN ANDREW M
SVP, Regulatory and Quality
Sale 10b5-1
- Shares
- 30,000
- Price
- $20.69
- Value
- $620,820
GREEN ANDREW M
SVP, Regulatory and Quality
Sale 10b5-1
- Shares
- 14,001
- Price
- $20.71
- Value
- $289,919
Holloway Jean F
SVP, General Counsel
SaleAlert
- Shares
- 8,962
- Price
- $38.00
- Value
- $340,556
Davis John E
Chief Commercial Officer
SaleAlert
- Shares
- 5,000
- Price
- $45.11
- Value
- $225,550
Mackin James P
President & CEO
Sale 10b5-1
- Shares
- 30,921
- Price
- $45.46
- Value
- $1,405,700
Holloway Jean F
SVP, General Counsel
SaleAlert
- Shares
- 5,267
- Price
- $45.30
- Value
- $238,595
Holloway Jean F
SVP, General Counsel
SaleAlert
- Shares
- 2,048
- Price
- $45.30
- Value
- $92,774
Mackin James P
President & CEO
Sale 10b5-1
- Shares
- 30,921
- Price
- $45.56
- Value
- $1,408,730
Stanton Marshall S.
SVP, Clinical & MD Affair
SaleAlert
- Shares
- 8,370
- Price
- $45.35
- Value
- $379,538
Stanton Marshall S.
SVP, Clinical & MD Affair
SaleAlert
- Shares
- 18,705
- Price
- $44.91
- Value
- $840,042
Stanton Marshall S.
SVP, Clinical & MD Affair
SaleAlert
- Shares
- 5,715
- Price
- $45.35
- Value
- $259,152
Stanton Marshall S.
SVP, Clinical & MD Affair
SaleAlert
- Shares
- 14,586
- Price
- $44.92
- Value
- $655,189
Stanton Marshall S.
SVP, Clinical & MD Affair
SaleAlert
- Shares
- 1,355
- Price
- $44.28
- Value
- $59,997
Stanton Marshall S.
SVP, Clinical & MD Affair
SaleAlert
- Shares
- 2,033
- Price
- $44.32
- Value
- $90,092
Stanton Marshall S.
SVP, Clinical & MD Affair
SaleAlert
- Shares
- 11,888
- Price
- $44.14
- Value
- $524,736
Hoff Elizabeth A
Director
SaleAlert
- Shares
- 4,200
- Price
- $45.10
- Value
- $189,412
Holloway Jean F
SVP, General Counsel
Sale 10b5-1
- Shares
- 6,394
- Price
- $45.17
- Value
- $288,817
Davis John E
Chief Commercial Officer
Sale 10b5-1
- Shares
- 6,394
- Price
- $45.17
- Value
- $288,817
Horton Amy
VP, Chief Accounting Officer
SaleAlert
- Shares
- 6,000
- Price
- $45.73
- Value
- $274,380
Holloway Jean F
SVP, General Counsel
Sale 10b5-1
- Shares
- 6,393
- Price
- $45.00
- Value
- $287,685
Davis John E
Chief Commercial Officer
Sale 10b5-1
- Shares
- 6,393
- Price
- $44.67
- Value
- $285,575
Holloway Jean F
SVP, General Counsel
SaleAlert
- Shares
- 10,000
- Price
- $46.18
- Value
- $461,800
Stanton Marshall S.
SVP, Clinical & MD Affair
SaleAlert
- Shares
- 18,200
- Price
- $44.02
- Value
- $801,219
Holloway Jean F
SVP, General Counsel
SaleAlert
- Shares
- 10,000
- Price
- $44.37
- Value
- $443,700
Mackin James P
President & CEO
SaleAlert
- Shares
- 12,500
- Price
- $42.32
- Value
- $528,988
Davis John E
Chief Commercial Officer
SaleAlert
- Shares
- 10,802
- Price
- $43.67
- Value
- $471,756
Holloway Jean F
SVP, General Counsel
SaleAlert
- Shares
- 6,381
- Price
- $43.02
- Value
- $274,498
Holloway Jean F
SVP, General Counsel
SaleAlert
- Shares
- 16,975
- Price
- $43.01
- Value
- $730,112
Horton Amy
VP, Chief Accounting Officer
Sale 10b5-1
- Shares
- 7,992
- Price
- $38.49
- Value
- $307,612
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | GREEN ANDREW M SVP, Regulatory and Quality | Sale | 11,480 | $24.97 | $286,656 | |
| Sep 03, 2026 | GREEN ANDREW M SVP, Regulatory and Quality | Sale | 1,493 | $26.02 | $38,842 | |
| Sep 02, 2026 | GREEN ANDREW M SVP, Regulatory and Quality | Sale | 6,510 | $27.27 | $177,495 | |
| Aug 19, 2026 | Mackin James P President & CEO | Sale | 70,000 | $28.96 | $2,026,850 | |
| Aug 12, 2026 | Holloway Jean F SVP, General Counsel | Sale | 977 | $28.49 | $27,835 | |
| Jun 11, 2026 | GREEN ANDREW M SVP, Regulatory and Quality | Sale | 30,000 | $20.69 | $620,820 | |
| Jun 11, 2026 | GREEN ANDREW M SVP, Regulatory and Quality | Sale | 14,001 | $20.71 | $289,919 | |
| Mar 04, 2026 | Holloway Jean F SVP, General Counsel | Sale | 8,962 | $38.00 | $340,556 | |
| Dec 15, 2025 | Davis John E Chief Commercial Officer | Sale | 5,000 | $45.11 | $225,550 | |
| Dec 03, 2025 | Mackin James P President & CEO | Sale | 30,921 | $45.46 | $1,405,700 | |
| Dec 03, 2025 | Holloway Jean F SVP, General Counsel | Sale | 5,267 | $45.30 | $238,595 | |
| Dec 03, 2025 | Holloway Jean F SVP, General Counsel | Sale | 2,048 | $45.30 | $92,774 | |
| Dec 02, 2025 | Mackin James P President & CEO | Sale | 30,921 | $45.56 | $1,408,730 | |
| Nov 21, 2025 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | 8,370 | $45.35 | $379,538 | |
| Nov 21, 2025 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | 18,705 | $44.91 | $840,042 | |
| Nov 21, 2025 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | 5,715 | $45.35 | $259,152 | |
| Nov 21, 2025 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | 14,586 | $44.92 | $655,189 | |
| Nov 20, 2025 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | 1,355 | $44.28 | $59,997 | |
| Nov 20, 2025 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | 2,033 | $44.32 | $90,092 | |
| Nov 20, 2025 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | 11,888 | $44.14 | $524,736 | |
| Nov 18, 2025 | Hoff Elizabeth A Director | Sale | 4,200 | $45.10 | $189,412 | |
| Nov 17, 2025 | Holloway Jean F SVP, General Counsel | Sale | 6,394 | $45.17 | $288,817 | |
| Nov 17, 2025 | Davis John E Chief Commercial Officer | Sale | 6,394 | $45.17 | $288,817 | |
| Nov 17, 2025 | Horton Amy VP, Chief Accounting Officer | Sale | 6,000 | $45.73 | $274,380 | |
| Nov 14, 2025 | Holloway Jean F SVP, General Counsel | Sale | 6,393 | $45.00 | $287,685 | |
| Nov 14, 2025 | Davis John E Chief Commercial Officer | Sale | 6,393 | $44.67 | $285,575 | |
| Nov 11, 2025 | Holloway Jean F SVP, General Counsel | Sale | 10,000 | $46.18 | $461,800 | |
| Aug 27, 2025 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | 18,200 | $44.02 | $801,219 | |
| Aug 25, 2025 | Holloway Jean F SVP, General Counsel | Sale | 10,000 | $44.37 | $443,700 | |
| Aug 15, 2025 | Mackin James P President & CEO | Sale | 12,500 | $42.32 | $528,988 | |
| Aug 12, 2025 | Davis John E Chief Commercial Officer | Sale | 10,802 | $43.67 | $471,756 | |
| Aug 12, 2025 | Holloway Jean F SVP, General Counsel | Sale | 6,381 | $43.02 | $274,498 | |
| Aug 12, 2025 | Holloway Jean F SVP, General Counsel | Sale | 16,975 | $43.01 | $730,112 | |
| Aug 08, 2025 | Horton Amy VP, Chief Accounting Officer | Sale | 7,992 | $38.49 | $307,612 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.